- Home
- CNTA vs SOC Comparison
CNTA vs SOC Comparison
Compare CNTA & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | SOC |
|---|---|---|
| Founded | 2020 | 2020 |
| Country | United Kingdom | United States |
| Employees | N/A | 200 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 2.3B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTA | SOC |
|---|---|---|
| Price | $40.01 | $10.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $43.17 | $17.33 |
| AVG Volume (30 Days) | 1.3M | ★ 3.8M |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.30 | $3.72 |
| 52 Week High | $40.26 | $32.18 |
Technical Indicators
Market Signals| Indicator | CNTA | SOC |
|---|---|---|
| Relative Strength Index (RSI) | 69.06 | 33.02 |
| Support Level | $39.58 | $6.75 |
| Resistance Level | $40.26 | $15.27 |
| Average True Range (ATR) | 0.18 | 1.18 |
| MACD | -0.06 | -0.32 |
| Stochastic Oscillator | 93.33 | 10.09 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About SOC Sable Offshore Corp.
Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.